These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 33572604)

  • 1. Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge.
    Kamimura H; Sato T; Natsui K; Kobayashi T; Yoshida T; Kamimura K; Tsuchiya A; Murayama T; Yokoyama J; Kawai H; Takamura M; Terai S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia and chronic liver diseases.
    Hsu CS; Kao JH
    Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1229-1244. PubMed ID: 30791794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cause and management of muscle wasting in chronic liver disease.
    Dasarathy S
    Curr Opin Gastroenterol; 2016 May; 32(3):159-65. PubMed ID: 26974417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Nonpharmacological Interventions for Sarcopenia among Cirrhotic Patients.
    Abdelbasset WK; Nambi G; Elsayed SH; Moawd SA; Ibrahim AA; Verma A; Tantawy SA; Kamel DM; Saleh AK; Aldhafian OR; Nwihadh NB
    Dis Markers; 2021; 2021():8866093. PubMed ID: 33628339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of sarcopenia in patients with cirrhosis.
    Montano-Loza AJ
    World J Gastroenterol; 2014 Jul; 20(25):8061-71. PubMed ID: 25009378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions.
    Sinclair M; Gow PJ; Grossmann M; Angus PW
    Aliment Pharmacol Ther; 2016 Apr; 43(7):765-77. PubMed ID: 26847265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia in Patients with Advanced Liver Disease.
    Ponziani FR; Gasbarrini A
    Curr Protein Pept Sci; 2018; 19(7):681-691. PubMed ID: 28462693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of skeletal muscle abnormalities in patients with cirrhosis.
    Ebadi M; Montano-Loza AJ
    Dig Liver Dis; 2019 Nov; 51(11):1493-1499. PubMed ID: 31221549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle Mass Effect: The Importance of Diagnosing and Treating Sarcopenia in Patients with Advanced Chronic Liver Disease.
    Paternostro R
    Dig Dis Sci; 2023 Apr; 68(4):1089-1090. PubMed ID: 36881198
    [No Abstract]   [Full Text] [Related]  

  • 10. Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management.
    Elsheikh M; El Sabagh A; Mohamed IB; Bhongade M; Hassan MM; Jalal PK
    World J Gastroenterol; 2023 Dec; 29(46):6028-6048. PubMed ID: 38130738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New concepts in liver cirrhosis: clinical significance of sarcopenia in cirrhotic patients.
    Montano-Loza AJ
    Minerva Gastroenterol Dietol; 2013 Jun; 59(2):173-86. PubMed ID: 23831908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation.
    Carey EJ; Lai JC; Sonnenday C; Tapper EB; Tandon P; Duarte-Rojo A; Dunn MA; Tsien C; Kallwitz ER; Ng V; Dasarathy S; Kappus M; Bashir MR; Montano-Loza AJ
    Hepatology; 2019 Nov; 70(5):1816-1829. PubMed ID: 31220351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score.
    Kim HY; Jang JW
    World J Gastroenterol; 2015 Jul; 21(25):7637-47. PubMed ID: 26167066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia in chronic liver disease: mechanisms and countermeasures.
    Allen SL; Quinlan JI; Dhaliwal A; Armstrong MJ; Elsharkawy AM; Greig CA; Lord JM; Lavery GG; Breen L
    Am J Physiol Gastrointest Liver Physiol; 2021 Mar; 320(3):G241-G257. PubMed ID: 33236953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research advances of sarcopenia in chronic liver disease].
    Xiao HJ; Zhang M; Qi YM; Han T
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):563-566. PubMed ID: 31357787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sarcopenia in liver disease].
    Nishiguchi S; Nishikawa H; Enomoto H
    Nihon Shokakibyo Gakkai Zasshi; 2018; 115(5):415-423. PubMed ID: 29743449
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment for sarcopenia in patients with chronic liver disease].
    Kawaguchi T; Nakano D; Torimura T
    Nihon Shokakibyo Gakkai Zasshi; 2018; 115(5):439-448. PubMed ID: 29743452
    [No Abstract]   [Full Text] [Related]  

  • 18. Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis.
    Bhanji RA; Narayanan P; Allen AM; Malhi H; Watt KD
    Hepatology; 2017 Dec; 66(6):2055-2065. PubMed ID: 28777879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sarcopenia in chronic liver diseases].
    Rau M
    Inn Med (Heidelb); 2023 Jun; 64(6):525-531. PubMed ID: 37219562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrition and the transplant candidate.
    Mazurak VC; Tandon P; Montano-Loza AJ
    Liver Transpl; 2017 Nov; 23(11):1451-1464. PubMed ID: 29072825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.